<DOC>
	<DOCNO>NCT00539071</DOCNO>
	<brief_summary>The purpose study look two dos long-acting injectable risperidone ( Risperdal Consta ) . The study use usual dose Risperdal Consta ( 50 mg give every two week ) high dose ( 75 mg-100 mg give every two week ) see one good improving symptom schizophrenia schizoaffective disorder .</brief_summary>
	<brief_title>High Dose Risperidone Consta Patients With Schizophrenia With Poor Response Risperidone</brief_title>
	<detailed_description>This six month double-blind , randomize trial design compare efficacy high dose long act risperidone ( 75 mg-100 mg q2 week equivalent ) standard dose long act risperidone ( ≤50 mg/q 2weeks ) Total Psychopathology , positive , negative , depressive symptom , cognition patient consider poor responder , significant others , clinician . This include two type inadequately respond patients—those treatment resistant research criterion ( Kane et al. , 1988 ) inadequate response</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<criteria>Patients diagnose schizophrenia schizoaffective disorder Able give write informed consent . Moderate psychosis persist although compliant medication Patients must inadequate response two antipsychotic medication ( risperidone , oral long act require ) , dose within upper end standard dosage range Patients must Clinical Global Impression Severity ( CGIS ) scale score screen least moderate severity PSP score 60 . At time screening , eligible patient receive receive treatment risperidone oral Consta , combination exceed 50 mg q 2 week Consta oral risperidone 8 mg/day least 6 week within seven year study entry without satisfactory response document medical record Risperidone Patients receive Consta injectable medication within specify dose range month prior onset study eligible . Patients receive mood stabilizer antidepressant , , addition risperidone oral Consta , eligible Patients may initially inpatients outpatient Females child bear potential admit stable birth control medication understand get pregnant course study . All patient must stable housing current time plan housing follow hospital discharge , inpatient . Patients must willing receive injectable medication Patients diagnosis schizophrenia schizoaffective disorder . Patients previously treat dose agent higher allow least six month fail adequate response exclude Patients currently take clozapine fail adequate trial clozapine last least 3 month Pregnant female . Females currently breastfeed exclude . Patients diagnosis substance dependence screen one year prior enrollment . Patient bad mild tardive dyskinesia history mark EPS screen Patients neuroleptic malignant syndrome Patients history galactorrhea Patients uncontrolled medical condition ( ) Patients history noncompliance oral injectable medication . Patients unwilling injectable medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>schizophrenia</keyword>
	<keyword>schizoaffective disorder</keyword>
	<keyword>long act injectable</keyword>
	<keyword>treatment resistant</keyword>
</DOC>